Biologically active additives are food additives intended to improve health with regular use and containing components of natural or identical to natural biologically active substances in order to enrich the human diet with them. That is, dietary supplements are not a medicine. The quality of dietary supplements must meet the requirements of the technical regulations of the Customs Union "On the safety of food products". Since dietary supplements are food products, their production and sale are regulated by Sanitary Rules. An essential stage of dietary supplement registration is research (testing) in accredited laboratories. These measures are aimed at protecting the consumer. Activities related to the circulation of biologically active additives are not subject to licensing. In Kazakhstan, dietary supplements are subject to mandatory state registration. State registration/re-registration of dietary supplements in our republic is carried out by the Committee for Sanitary and Epidemiological Control of the Ministry of Health of the Republic of Kazakhstan.
As shown by the product safety check conducted by the Almaty sanitary and epidemiological control specialists in 2022, a huge range of dietary supplements is sold in the country, most of which are not registered in the EAEU and do not have information for the consumer in Kazakh or Russian.
Labeling serves to reduce the amount of counterfeit and falsified products on the domestic market. The regulator is confident that digital identification codes on dietary supplements guarantee the buyer the purchase of legal, certified products. In 2025, a pilot stage of labeling dietary supplements will begin, which will take up to 1.5 years, and only after its successful completion will the possibility of introducing mandatory labeling be considered - and this is 2026 or 2027. The introduction of mandatory labeling takes place in several stages. First, a pilot project. Labeling is tested on those companies that want to participate in the "pilot" and technical capabilities are tested, selecting optimal solutions. Then there is a public discussion and analysis (3-6 months), hearings with market participants and the public. After - approval: coordination with the Atameken NCE and the entry into force of the decision.
It should also be noted that according to the Ministry of Trade, as part of the introduction of drug labeling, 8.3 million drug packages were labeled in Kazakhstan in 2023. In 2024 - 175.2 million packages. At the moment, 65.5 million drugs are in circulation, of which 36.8 million are imported, and 28.7 million are domestic. 7.24 million drugs have been withdrawn from circulation.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
As shown by the product safety check conducted by the Almaty sanitary and epidemiological control specialists in 2022, a huge range of dietary supplements is sold in the country, most of which are not registered in the EAEU and do not have information for the consumer in Kazakh or Russian.
Labeling serves to reduce the amount of counterfeit and falsified products on the domestic market. The regulator is confident that digital identification codes on dietary supplements guarantee the buyer the purchase of legal, certified products. In 2025, a pilot stage of labeling dietary supplements will begin, which will take up to 1.5 years, and only after its successful completion will the possibility of introducing mandatory labeling be considered - and this is 2026 or 2027. The introduction of mandatory labeling takes place in several stages. First, a pilot project. Labeling is tested on those companies that want to participate in the "pilot" and technical capabilities are tested, selecting optimal solutions. Then there is a public discussion and analysis (3-6 months), hearings with market participants and the public. After - approval: coordination with the Atameken NCE and the entry into force of the decision.
It should also be noted that according to the Ministry of Trade, as part of the introduction of drug labeling, 8.3 million drug packages were labeled in Kazakhstan in 2023. In 2024 - 175.2 million packages. At the moment, 65.5 million drugs are in circulation, of which 36.8 million are imported, and 28.7 million are domestic. 7.24 million drugs have been withdrawn from circulation.
Источник: Казахстанский Фармацевтический Вестник, pharmnews.kz
